Literature DB >> 25696139

The importance of patency of the infarct-related artery in treatment of patients with acute myocardial infarction.

N Ernst, F Zijlstra, M J de Boer, J H E Dambrink, A T M Gosselink, J P S Henriques, A W J van 't Hof, J C A Hoorntje, J C C van der Horst, H Suryapranata.   

Abstract

OBJECTIVE: To study the impact of patency of the infarct-related artery on the coronary angiogram, both before and after primary angioplasty for acute myocardial infarction, on 30-day mortality.
METHOD: Data of 1702 consecutive patients treated with primary angioplasty for acute myocardial infarction were collected prospectively from 1994 to 2000.
RESULTS: Patients with a (partially) patent infarct artery before primary angioplasty had less damage to the myocardium and a lower 30-day mortality (1.6% versus 3.4%, p=0.04) compared with patients with an occluded artery. Patients with pre-hospital treatment with aspirin and heparin more often presented with a patent artery before angioplasty (31% versus 20%, p<0.001). After primary angioplasty, 95% of patients had a patent artery with a 30-day mortality of 2.2%. The 5% of patients with failed angioplasty had extensive myocardial damage and a 30-day mortality rate of 17%.
CONCLUSION: Patency of the infarct-related artery on the coronary angiogram, both before and after primary angioplasty, has a major impact on 30-day mortality.

Entities:  

Keywords:  acute myocardial infarction; coronary patency; primary angioplasty

Year:  2003        PMID: 25696139      PMCID: PMC2499828     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  16 in total

1.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.

Authors:  A Schömig; A Kastrati; J Dirschinger; J Mehilli; U Schricke; J Pache; S Martinoff; F J Neumann; M Schwaiger
Journal:  N Engl J Med       Date:  2000-08-10       Impact factor: 91.245

2.  [Surgical interventions in acute myocardial infarction].

Authors:  F Zijlstra; M J de Boer
Journal:  Ned Tijdschr Geneeskd       Date:  1996-09-28

3.  Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state.

Authors:  B A Vakili; R Kaplan; D L Brown
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

4.  A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.

Authors:  A M Ross; K S Coyne; J S Reiner; S W Greenhouse; C Fink; A Frey; E Moreyra; M Traboulsi; N Racine; A L Riba; M A Thompson; S Rohrbeck; C F Lundergan
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

5.  Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study.

Authors:  L F van den Merkhof; F Zijlstra; H Olsson; L Grip; G Veen; F W Bär; M J van den Brand; M L Simoons; F W Verheugt
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

6.  Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials.

Authors:  G W Stone; D Cox; E Garcia; B R Brodie; M C Morice; J Griffin; L Mattos; A J Lansky; W W O'Neill; C L Grines
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

7.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

Authors:  W D Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

8.  [Identical results of primary percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction admitted as a result of direct or indirect referral].

Authors:  F Zijlstra; H Suryapranata; A W van 't Hof; J C Hoorntje; A L Liem; M J de Boer
Journal:  Ned Tijdschr Geneeskd       Date:  1999-03-06

9.  [Clinical presentations mimicking acute myocardial infarction; therapeutic pitfalls].

Authors:  P Elsman; M A Alleman; F Zijlstra
Journal:  Ned Tijdschr Geneeskd       Date:  1998-05-09

10.  The relationship between coronary angioplasty procedure volume and major complications.

Authors:  S E Kimmel; J A Berlin; W K Laskey
Journal:  JAMA       Date:  1995-10-11       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.